Primary Site >> Liver Cancer
Gene >> CYP7A1
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase. PMID: 10823815 |
Ref: Repression of farnesoid X receptor during the acute phase response. PMID: 12519762 |
Ref: Transcriptional toxicity of the Yangtze River source water on mouse (Mus musculus) detected by cDNA microarray. PMID: 19499331 Ref: Actein activates stress- and statin-associated responses and is bioavailable in Sprague-Dawley rats. PMID: 19527300 |
Ref: Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. PMID: 20842632 |
Ref: [Effect of interfering hepatocyte nuclear factor-1 alfa in HepG2 on the expressions of apoM, apoA-I and the correlative key enzyme of cholesterol metabolism]. PMID: 21492516 Ref: Expression of SLCO1B3 is associated with intratumoral cholestasis and CTNNB1 mutations in hepatocellular carcinoma. PMID: 21615622 |
Ref: A simple and economical route to generate functional hepatocyte-like cells from hESCs and their application in evaluating alcohol induced liver damage. PMID: 21956183 |
Ref: SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. PMID: 24338587 Ref: Activated AMPK explains hypolipidemic effects of sulfated low molecular weight guluronate on HepG2 cells. PMID: 25089813 Ref: Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor. PMID: 25278094 |
Ref: Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation. PMID: 24954587 |
Ref: The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction. PMID: 27153767 |
Ref: Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. PMID: 27923447 Ref: Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma. PMID: 28445152 Ref: Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma. PMID: 28751722 |
Ref: Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation. PMID: 29432567 Ref: A novel zebrafish intestinal tumor model reveals a role for cyp7a1-dependent tumor-liver crosstalk in causing adverse effects on the host. PMID: 29592890 Ref: Hepatoprotection of auraptene from peels of citrus fruits against thioacetamide-induced hepatic fibrosis in mice by activating farnesoid X receptor. PMID: 29721568 Ref: N-3 Polyunsaturated Fatty Acids Stimulate Bile Acid Detoxification in Human Cell Models. PMID: 29850457 Ref: Ganoderma Lucidum Polysaccharide Peptide Alleviates Hepatoteatosis via Modulating Bile Acid Metabolism Dependent on FXR-SHP/FGF. PMID: 30196282 Ref: The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19. PMID: 30223181 |